AI in Mammography
Improving breast cancer screening with artificial intelligence
We’re working with clinicians, patients, and partners to build an AI system for mammography, which could help radiologists detect breast cancer more accurately, quickly, and consistently.



We’re working with partners to test this technology with real patients and clinicians
-
We’ve worked with Northwestern Medicine to research how the research model can help prioritize high risk cases and shorten time to diagnosis for screened individuals.
-
We are working with Imperial College London and three NHS trusts to understand whether the research model can act as a “second independent reader” in UK double read screening systems and allow radiologists to focus on high priority cases while improving consistency and quality of screening.
Types of cancers and outcomes vary by demographic
Breast density varies by race and ethnicity, so ensuring that our datasets are representative of different demographics is crucial in creating an effective and inclusive tool for all, regardless of race or ethnicity.
We are partnering with the Japanese Foundation for Cancer Research (JFCR) at Ariake Hospital to improve the inclusivity of our models, and are continuing to explore how we can make our products more representative.
We are partnering with the Japanese Foundation for Cancer Research (JFCR) at Ariake Hospital to improve the inclusivity of our models, and are continuing to explore how we can make our products more representative.

Breast cancer is a cancer that has a very high probability of being cured if found at an early stage. By using AI technology for cancer screening, we can maintain the accuracy of diagnosis and reduce the burden on radiologists, even if many people undergo medical checkup.
PROF. YUSUKE NAKAMURA
Director for Strategic Innovation Promotion Program “AI Hospital” initiative, Japanese Cabinet Office and Advisor of The Cancer Institute of JFCR